Clinical trial
Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
NCT05932472 is registered in ClinicalTrials.gov with Tor Biering-Sørensen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
- Lead sponsor
- Tor Biering-Sørensen
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 15, 2024
- Completion date
- February 15, 2027
- Enrollment
- 32,706 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, cardiovascular diseases, drug effect